Home results
 

Keywords :   


Tag: results

California ARB issues feedstock-only pathway for camelina-based fuels under LCFS; zero ILUC emissions results in very low CI fuels

2015-02-05 16:55:32| Green Car Congress

Tags: results very low issues

 

Hub Group (HUBG) Q4 2014 Results - Earnings Call Webcast

2015-02-05 02:46:34| Logistics - Topix.net

The following audio is from a conference call that will begin on February 04, 2015 at 17:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

Tags: results group call earnings

 
 

Whirlpool Corporation Reports Full-Year 2014 Results And Reaffirms 2015 Guidance

2015-02-05 02:08:00| Appliances - Topix.net

Whirlpool Corporation announced today fourth-quarter GAAP net earnings of $81 million, or $1.02 per diluted share, compared to $181 million, or $2.26 per diluted share, reported for the same prior-year period. GAAP results reflect $1.71 per diluted share in costs associated with the two recent acquisitions.

Tags: results reports corporation guidance

 

Shares of Ralph Lauren drop on weak 3Q results

2015-02-04 16:52:18| Apparel - Topix.net

Ralph Lauren Corp.'s fiscal third-quarter net income fell 9 percent as the company spent more on opening new stores and marketing while revenue stayed nearly flat. The results for the retailer missed expectations and shares and the company trimmed its 2015 revenue forecast as well.

Tags: results drop shares weak

 

Merck Announces Fourth-Quarter and Full-Year 2014 Financial Results

2015-02-04 13:02:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. Fourth-Quarter 2014 Non-GAAP EPS of $0.87, Excluding Certain Items; GAAP EPS of $2.54; Full-Year 2014 Non-GAAP EPS of $3.49, Excluding Certain Items; GAAP EPS of $4.07 2015 Full-Year Non-GAAP EPS Target of $3.32 to $3.47, Including a $0.27 Negative Impact From Foreign Exchange and Excluding Certain Items; GAAP EPS Range of $1.62 to $1.91 Fourth-Quarter 2014 Worldwide Sales of $10.5 Billion, a Decrease of 7 Percent, Reflecting Unfavorable Impact of Patent Expiries and Divestitures and a 3 Percent Negative Impact From Foreign Exchange Full-Year 2014 Worldwide Sales of $42.2 Billion, a Decrease of 4 Percent, Reflecting Unfavorable Impact of Patent Expiries and Divestitures and a 1 Percent Negative Impact From Foreign Exchange Full-Year Results Reflect Sales Growth in Immunology, Diabetes, Hospital Acute Care, Vaccines and Animal Health and Sales Declines in Hepatitis C Six New Products Were Approved in the United States in 2014; Company Accelerated KEYTRUDA and Hepatitis C Clinical Development Programs KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2014. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036Steven Cragle, 908-740-1801orInvestors:Justin Holko, 908-740-1879Joe Romanelli, 908-740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: results financial announces merck

 

Sites : [609] [610] [611] [612] [613] [614] [615] [616] [617] [618] [619] [620] [621] [622] [623] [624] [625] [626] [627] [628] next »